The Progression of Stargardt Disease as Determined by Spectral-Domain Optical Coherence Tomography over a 24-Month Period (ProgStar Report No. 18)

Authors

Janet S. Sunness, Greater Baltimore Medical Center (GBMC)

Document Type

Article

Publication Title

Ophthalmic Research

First Page

435

Last Page

447

DOI

https://doi.org/10.1159/000540028

Publication Date

7-18-2024

Comments

PubMed: 39004077

Recommended Citation

Rupert Wolfgang Strauss, Lang Lang, Alexander Ho, Anamika Jha, Michael Ip, Paul S. Bernstein, David G. Birch, Artur V. Cideciyan, Michel Michaelides, Isabelle Audo, Janet S. Sunness, Elias I. Traboulsi, Eberhart Zrenner, SriniVas R. Sadda, Lucas Janeschitz-Kriegl, Sheila West, Xiangrong Kong, Hendrik P.N. Scholl, for the ProgStar Study Group; The Progression of Stargardt Disease as Determined by Spectral-Domain Optical Coherence Tomography over a 24-Month Period (ProgStar Report No. 18). Ophthalmic Res 24 May 2024; 67 (1): 435–447. https://doi.org/10.1159/000540028